# Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/TCMD/tactile-systems-technology-inc-reports-first-quarter-2026-financial-results
Ticker: TCMD
Company: Tactile Systems Technology, Inc.
Source: Tactile Systems Technology, Inc.
Published: 2026-05-04 20:05 EST
Original Source URL: https://investors.tactilemedical.com
## Summary

MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2026.

## Article Body
MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2026.
## Recent Company News
- 2026-07-13 12:00 EST — [Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients](https://biopharmsignal.com/news/TCMD/tactile-medical-enters-exclusive-u-s-distribution-agreement-with-elastimed-for-i-116aea64) — Source: Tactile Systems Technology, Inc.
- 2026-06-02 12:00 EST — [Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy](https://biopharmsignal.com/news/TCMD/tactile-medical-launches-next-generation-afflovestr-airway-clearance-therapy) — Source: Tactile Systems Technology, Inc.
- 2026-05-20 20:05 EST — [Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference](https://biopharmsignal.com/news/TCMD/tactile-medical-to-present-at-the-william-blair-46th-annual-growth-stock-conference) — Source: Tactile Systems Technology, Inc.
- 2026-05-04 20:05 EST — [Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TCMD/tactile-systems-technology-inc-reports-first-quarter-2026-financial-results) — Source: Tactile Systems Technology, Inc.
- 2026-04-20 20:05 EST — [Tactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-first-quarter-of-fiscal-year-2026-financial-results-on-may-4-2026) — Source: Tactile Systems Technology, Inc.
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)